Compare GMED & SOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GMED | SOLS |
|---|---|---|
| Founded | 2003 | 2025 |
| Country | United States | United States |
| Employees | N/A | 4400 |
| Industry | Medical/Dental Instruments | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.5B |
| IPO Year | 2012 | N/A |
| Metric | GMED | SOLS |
|---|---|---|
| Price | $86.16 | $72.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $100.42 | $72.75 |
| AVG Volume (30 Days) | 947.4K | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-03-2026 |
| Dividend Yield | N/A | ★ 0.45% |
| EPS Growth | ★ 422.67 | N/A |
| EPS | ★ 3.92 | N/A |
| Revenue | ★ $2,938,931,000.00 | N/A |
| Revenue This Year | $11.13 | $6.46 |
| Revenue Next Year | $6.28 | $5.00 |
| P/E Ratio | ★ $21.94 | $54.31 |
| Revenue Growth | ★ 16.65 | N/A |
| 52 Week Low | $51.79 | $40.43 |
| 52 Week High | $101.40 | $84.44 |
| Indicator | GMED | SOLS |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 50.33 |
| Support Level | $85.61 | $70.72 |
| Resistance Level | $87.77 | $83.07 |
| Average True Range (ATR) | 2.02 | 3.41 |
| MACD | -0.14 | -0.89 |
| Stochastic Oscillator | 26.25 | 46.15 |
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.